Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Raffa

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Neuroscience and Biobehavioral Reviews|December 19, 2000
Insulin receptors and insulin action in the brain: review and clinical implicationsR J Schulingkamp, T C Pagano, D Hung, et al.
Journal of Cardiovascular Pharmacology|September 1, 1985
Altered vascular responsiveness to norepinephrine following withdrawal of verapamil in rabbitsJ F Aceto, J Kitzen, R B Raffa, et al.
Journal of Clinical Pharmacy and Therapeutics|March 11, 2018
The role and mechanism of action of menthol in topical analgesic productsJ V Pergolizzi, R Taylor, J-A LeQuang, et al.
European Journal of Pharmacology|February 15, 1993
Thermodynamic parameters for [D-Pen2,5]enkephalin at delta-opioid receptors in the mouse isolated vas deferensR B Raffa, K D Wild, H I Mosberg, et al.
Journal of Clinical Pharmacy and Therapeutics|September 19, 2017
The "Darknet": The new street for street drugsJ V Pergolizzi, J A LeQuang, R Taylor, et al.
Life Sciences|October 6, 2000
Is there a basis for novel pharmacotherapy of autism?D M Hunsinger, T Nguyen, S E Zebraski, et al.
Journal of Clinical Pharmacy and Therapeutics|March 10, 2018
Nature's first "atypical opioids": Kratom and mitragyninesR B Raffa, J V Pergolizzi, R Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptorsK D Wild, F Porreca, H I Yamamura, et al.
Journal of Clinical Pharmacy and Therapeutics|June 30, 2005
A second (non-genomic) steroid mechanism of action: possible opportunity for novel pharmacotherapy?M A Craig, G A Beppler, C Santos, et al.
Journal of Clinical Pharmacy and Therapeutics|May 4, 2018
Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs)R B Raffa, J V Pergolizzi, R Taylor, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Neuroscience and Biobehavioral Reviews|December 19, 2000
Insulin receptors and insulin action in the brain: review and clinical implicationsR J Schulingkamp, T C Pagano, D Hung, et al.
Journal of Cardiovascular Pharmacology|September 1, 1985
Altered vascular responsiveness to norepinephrine following withdrawal of verapamil in rabbitsJ F Aceto, J Kitzen, R B Raffa, et al.
Journal of Clinical Pharmacy and Therapeutics|March 11, 2018
The role and mechanism of action of menthol in topical analgesic productsJ V Pergolizzi, R Taylor, J-A LeQuang, et al.
European Journal of Pharmacology|February 15, 1993
Thermodynamic parameters for [D-Pen2,5]enkephalin at delta-opioid receptors in the mouse isolated vas deferensR B Raffa, K D Wild, H I Mosberg, et al.
Journal of Clinical Pharmacy and Therapeutics|September 19, 2017
The "Darknet": The new street for street drugsJ V Pergolizzi, J A LeQuang, R Taylor, et al.
Life Sciences|October 6, 2000
Is there a basis for novel pharmacotherapy of autism?D M Hunsinger, T Nguyen, S E Zebraski, et al.
Journal of Clinical Pharmacy and Therapeutics|March 10, 2018
Nature's first "atypical opioids": Kratom and mitragyninesR B Raffa, J V Pergolizzi, R Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptorsK D Wild, F Porreca, H I Yamamura, et al.
Journal of Clinical Pharmacy and Therapeutics|June 30, 2005
A second (non-genomic) steroid mechanism of action: possible opportunity for novel pharmacotherapy?M A Craig, G A Beppler, C Santos, et al.
Journal of Clinical Pharmacy and Therapeutics|May 4, 2018
Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs)R B Raffa, J V Pergolizzi, R Taylor, et al.
Pageof 18